Harrow Health, Inc. (HROW)
NASDAQ: HROW · IEX Real-Time Price · USD
25.01
+0.42 (1.71%)
At close: Jul 19, 2024, 4:00 PM
24.94
-0.07 (-0.28%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Harrow Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Harrow Health stock have an average target of 28, with a low estimate of 25 and a high estimate of 30. The average target predicts an increase of 11.96% from the current stock price of 25.01.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 21, 2024.
Analyst Ratings
The average analyst rating for Harrow Health stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $26 → $30 | Strong Buy | Maintains | $26 → $30 | +19.95% | Jun 21, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $20 → $25 | Strong Buy | Maintains | $20 → $25 | -0.04% | Jun 3, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $26 → $29 | Strong Buy | Reiterates | $26 → $29 | +15.95% | May 15, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $30 → $26 | Strong Buy | Maintains | $30 → $26 | +3.96% | Mar 22, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | +79.93% | Jul 20, 2023 |
Financial Forecast
Revenue This Year
188.43M
from 130.19M
Increased by 44.73%
Revenue Next Year
264.03M
from 188.43M
Increased by 40.12%
EPS This Year
-0.55
from -0.75
EPS Next Year
0.62
from -0.55
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 201.9M | 293.6M | 367.7M | 463.6M |
| Avg | 188.4M | 264.0M | 357.2M | 450.3M |
| Low | 174.7M | 227.5M | 343.2M | 432.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 55.0% | 55.8% | 39.3% | 29.8% |
| Avg | 44.7% | 40.1% | 35.3% | 26.1% |
| Low | 34.2% | 20.7% | 30.0% | 21.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.54 | 0.82 | 2.05 |
| Avg | -0.55 | 0.62 | 1.99 |
| Low | -0.60 | 0.30 | 1.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 232.0% |
| Avg | - | - | 222.5% |
| Low | - | - | 209.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.